Vimarsana
Biggest News Aggregation in the World

Page 7 - B Biontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Biontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Biontech Today - Breaking & Trending Today

Maryland officials expect a third of 5-11 year olds will get vaccine in first few weeks - Vimarsana News

Maryland officials expect a third of 5-11 year olds will get vaccine in first few weeks

Maryland officials said Wednesday they expect about a third of children ages 5 to 11 to get vaccinated against COVID-19 in the next three to four weeks, following federal approval Tuesday night of Pfizer-BioNTech's shots.

Biden touts child COVID-19 vaccines after dismal election night - Vimarsana News

Biden touts child COVID-19 vaccines after dismal election night

President Biden said Wednesday that COVID-19 vaccines for school-aged kids will be widely available across the U.S. by next week, latching onto the "giant step forward" in the pandemic fight in the wake of a bruising Election Day for Democrats.

Biden touts child COVID-19 vaccines after dismal election night - Vimarsana News

Biden touts child COVID-19 vaccines after dismal election night

President Biden said Wednesday that COVID-19 vaccines for school-aged kids will be widely available across the U.S. by next week, latching onto the "giant step forward" in the pandemic fight in the wake of a bruising Election Day for Democrats.

FDA delays decision on Moderna vaccine for adolescents - Vimarsana News

FDA delays decision on Moderna vaccine for adolescents

U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.

FDA paves way for Pfizer COVID-19 vaccinations in young kids - Vimarsana News

FDA paves way for Pfizer COVID-19 vaccinations in young kids

The Food and Drug Administration on Friday authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in children ages 5 to 11, a major step in making the shots available to school-aged kids by early November.